FAM
CALA

Fred Alger Management’s Calithera Biosciences, Inc CALA Stock Holding History

Fred Alger Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,800
Closed -$294K – 588
2018
Q3 		$294K Buy
2,800
+2,100
+300% +$200K ﹤0.01% 379
2018
Q2 		$70K Hold
700
– – ﹤0.01% 409
2018
Q1 		$88K Buy
700
+200
+40% +$31.2K ﹤0.01% 408
2017
Q4 		$84K Hold
500
– – ﹤0.01% 412
2017
Q3 		$158K Buy
500
+250
+100% +$78.9K ﹤0.01% 385
2017
Q2 		$74K Sell
250
-400
-62% -$107K ﹤0.01% 407
2017
Q1 		$150K Buy
+650
New +$112K ﹤0.01% 389
2016
Q4 		– Sell
-1,250
Closed -$81K – 536
2016
Q3 		$81K Buy
+1,250
New +$80.6K ﹤0.01% 386
2016
Q1 		– Sell
-4,200
Closed -$643K – 617
2015
Q4 		$643K Sell
4,200
-1,750
-29% -$262K ﹤0.01% 419
2015
Q3 		$646K Buy
5,950
+3,337
+128% +$432K ﹤0.01% 416
2015
Q2 		$373K Buy
2,613
+1,550
+146% +$359K ﹤0.01% 479
2015
Q1 		$349K Buy
+1,063
New +$378K ﹤0.01% 575

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fred Alger Management's CALA Position: Q4 2018 in Review

Fred Alger Management sold out of Calithera Biosciences, Inc (CALA) in Q4 2018, closing a stake of 2,800 shares — an estimated $294K sold.

Fred Alger Management first reported a position in CALA in Q1 2015 and held it in 12 quarters. The position peaked at $646K in Q3 2015. 77 funds tracked by Wall St. Rank hold CALA as of Q4 2018.

  • Fred Alger Management reported no remaining Calithera Biosciences, Inc position as of Q4 2018 after selling out during the quarter.
  • Fred Alger Management sold 2,800 Calithera Biosciences, Inc shares in Q4 2018, an estimated $294K.
  • Fred Alger Management first reported a position in Calithera Biosciences, Inc in Q1 2015 and held it in 12 quarters.
  • Fred Alger Management's Calithera Biosciences, Inc position peaked at $646K in Q3 2015.
  • 77 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2018.

Based on Fred Alger Management's 13F filing for Q4 2018, filed 14 Feb 2019.